# Osang Healthcare

Osang Healthcare is an Asset Manager based in Anyang, South Korea.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Anyang, South Korea
- **Region:** Asia
- **Address:** Anyang, South Korea
- **Assets under management:** Undisclosed
- **Website:** osanghc.com

## Regulatory record

- **Reports private funds:** No

## Sectors

- Digital Health
- Healthcare Services

## Questions

### Who runs investment decisions at Osang Healthcare?

Osang Healthcare does not publicly name its executives, board members, or investment committee. The website carries no leadership profiles, and no primary-source interview or regulatory filing identifying a CIO, CEO, or managing director has been located. The firm operates as a private company and has not volunteered governance details.

### How does Osang Healthcare source proprietary deal flow?

There is no public evidence that Osang Healthcare pursues external deal flow in the sense of private-equity or venture-capital investing. The firm describes itself as an in-vitro diagnostic manufacturer with a strategy of internal R&D and product-platform development. It does not mention any fund commitments, co-investments, or external startup allocations.

### What investment stages does Osang Healthcare typically target?

Osang Healthcare has not disclosed any investment-stage focus. The firm’s public materials describe it as a product manufacturer and health-platform builder, and no venture, growth-equity, or buyout activity has been attributed to it in available primary sources.

### Which sectors does Osang Healthcare explicitly avoid?

The company lists five areas of concentration — blood-glucose measurement, biochemical diagnosis, immunological diagnosis, molecular diagnosis, and health-functional foods — but has not published a negative sector screen. It does not mention therapeutic-pharma, imaging, or hospital-services lines, but neither has it publicly excluded them.

### What is Osang Healthcare’s known posture on co-investments alongside external GPs?

No co-investment posture is known. The firm has not disclosed a GP relationship, co-investment track record, or participation in club deals. Its public narrative focuses on in-house product development and manufacturing partnerships, not fund-level investing.

## Related profiles

- [Zero Carbon Systems](https://altss.com/profile/zero-carbon-systems)

---

Last updated: 2026-05-30T21:09:51.059Z

Canonical page: https://altss.com/profile/osang-healthcare-co

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology